Steroid-reducing Effects of Crisaborole

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 17, 2019

Primary Completion Date

February 16, 2024

Study Completion Date

February 16, 2024

Conditions
Atopic DermatitisEczema
Interventions
DRUG

Crisaborole

Participants will be instructed to apply crisaborole to affected areas with eczema.

DRUG

Hydrocortisone Ointment

Participants will be instructed to apply hydrocortisone to affected areas with eczema on face, armpits or groin.

DRUG

Triamcinolone ointment

Participants will be instructed to apply triamcinolone to affected areas on the body excluding face, armpits or groin.

DRUG

Aquaphor

Participants will be instructed to moisturize all over the body with Aquaphor.

Trial Locations (1)

21287

Johns Hopkins Hospital, Baltimore

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Johns Hopkins University

OTHER

NCT03832010 - Steroid-reducing Effects of Crisaborole | Biotech Hunter | Biotech Hunter